Publications by authors named "Erica Nakajima"

Claim this Profile
T
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial.
David Planchard, Hye Ryun Kim, Thatthan Suksombooncharoen, Rubi Li, Diego Cortinovis, Erica C Nakajima

J Thorac Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy.
Jelena Levi, Millie Das, Minal S Vasanawala, Deepti Behl, Martin Pomper, Erica Nakajima

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group.
Erica C Nakajima, Amber Simpson, Jan Bogaerts, Elisabeth G E de Vries, Richard Do

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.
Erica C Nakajima, Nicole Drezner, Xiaoxue Li, Pallavi S Mishra-Kalyani, Yajun Liu

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.
Erica C Nakajima, Paz J Vellanki, Erin Larkins, Somak Chatterjee, Pallavi S Mishra-Kalyani

Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
Xuguang Chen, Khadija Sheikh, Erica Nakajima, Cheng Ting Lin, Junghoon Lee

Oncologist· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event.
Erica C Nakajima, Evan J Lipson, Julie R Brahmer

J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.
Erica C Nakajima, Michael P Frankland, Tucker F Johnson, Sanja L Antic, Heidi Chen

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart in Hand.
Erica C Nakajima

Ann Intern Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma.
Erica Nakajima, Paul Leger, Ingrid A Mayer, Michael N Neuss, David D Chism

Kidney Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.
Erica C Nakajima, Charles Laymon, Matthew Oborski, Weizhou Hou, Lin Wang

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic symbiosis in cancer: refocusing the Warburg lens.
Erica C Nakajima, Bennett Van Houten

Mol Carcinog· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis